The moment has finally arrived. Elon Musk’s space venture, SpaceX, has made its public market debut, and the City is buzzing. For UK investors, this is not just another IPO. It is a potential paradigm shift in capital allocation. Let me give you three things to watch, stripped of the hype.
First, valuation. The private markets have already priced SpaceX at a nosebleed level, north of $125 billion. That is a multiple that would make even a tech unicorn blush. But here is the rub: SpaceX generates real revenue from launch services and Starlink subscriptions. The question is whether that revenue can justify the valuation in a rising rate environment. UK investors should compare this to our own listed aerospace firms, like Rolls-Royce or BAE Systems. The earnings yield gap is stark. If interest rates stay higher for longer, speculative growth stocks tend to get crushed. Watch the gilt yield spread; if it widens, buckle up.
Second, the capital flight risk. This IPO will be heavily allocated to US institutional investors. UK retail investors, through platforms like Hargreaves Lansdown, will get a sliver. But the real issue is capital migration. Money flowing into SpaceX is money leaving UK markets. Our FTSE 100 is already starved of liquidity. This listing could exacerbate that. The Chancellor should be worried. We need to ask: are we losing the next generation of wealth creation to the US? The answer, I fear, is yes.
Third, the regulatory angle. SpaceX is not a typical defence contractor. It is a disruptor. The UK government has been cozying up to Musk for Starlink contracts and potential launch sites. But there are questions about national security and data sovereignty. US export controls may restrict what UK investors can actually own if the company starts handing over technology to the Pentagon. Watch for the fine print in the prospectus. If there are clauses about foreign ownership limits, that could cap the upside for British shareholders.
In summary, SpaceX’s listing is a test for the entire market. It is a bet on innovation, but also a bet on liquidity and geopolitics. My advice? Treat it like a high-yield bond: high risk, high potential, but do not bet the farm. The bottom line is this: if you cannot stomach a 40% drawdown, stay away. If you can, buy small and watch the central bank moves. Because when the Fed sneezes, SpaceX catches a cold.
